Sign in

CIK 0001226616

  • Non-accelerated filer
  • Smaller reporting company

MEDICINOVA INC

Sign in to watch
Ticker
MNOV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330927979
Phone
+1 858-373-1500
Business address
4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA, CA, 92037
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,728,000
in 1 filing

Net −$1,728,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. 3D Investment Partners Pte. Ltd. −$1.7M Formerly 10% Owner sold 12% of stake

Reading 51 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-05-21 Morris Arlene Director Exercise or conversion +7,800 $2.40 $19K 8,800
2013-05-21 Morris Arlene Director Sale −8,800 $3.28 $29K 0
2013-05-21 Morris Arlene Director Exercise or conversion · Stock Option (Right to Buy) −1,000 0
2013-05-21 Morris Arlene Director Exercise or conversion · Stock Option (Right to Buy) −7,800 36,200
2013-05-13 Okajima Masatsune VP and Head of Japanese Office Grant or award · Stock Option (Right to Buy) +42,500 42,500
2013-05-13 Matsuda Kazuko Chief Medical Officer Grant or award · Stock Option (Right to Buy) +42,500 42,500
2013-05-13 COFFEE MICHAEL DENIS Chief Business Officer Grant or award · Stock Option (Right to Buy) +42,500 42,500
2013-05-13 Johnson Kirk William Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +42,500 42,500
2013-05-13 IWAKI YUICHI President and CEO Grant or award · Stock Option (Right to Buy) +62,500 62,500
2013-05-13 Izumi Tatsuo Director Purchase +158,730 $3.15 $500K 158,730
2013-05-13 Izumi Tatsuo Director Purchase · Warrant to Purchase Common Stock +119,047 119,047
2012-06-14 Okajima Masatsune VP and Head of Japanese Office Grant or award · Stock Option (Right to Buy) +63,750 63,750
2012-06-14 Matsuda Kazuko Chief Medical Officer Grant or award · Stock Option (Right to Buy) +56,250 56,250
2012-06-14 Johnson Kirk William Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +63,750 63,750
2012-06-14 COFFEE MICHAEL DENIS Chief Business Officer Grant or award · Stock Option (Right to Buy) +63,750 63,750
2012-06-14 IWAKI YUICHI President and CEO Grant or award · Stock Option (Right to Buy) +86,250 86,250
2012-05-31 Izumi Tatsuo Director Purchase +5,200 $1.81 $9K 56,800
2012-05-29 Izumi Tatsuo Director Purchase +6,600 $1.98 $13K 51,600
2012-05-29 O'Toole David D Director Purchase +5,000 $1.78 $9K 5,000
2012-05-28 Izumi Tatsuo Director Purchase +30,000 $1.94 $58K 45,000

Page 11 of 15 · 292 trades